The government of Switzerland has signed a deal with Moderna to secure early access to 4.5 million doses of a coronavirus vaccine under development, reported SwissInfo.
The vaccine, with ingredients manufactured by Lonza, is based on mRNA technology.
Swiss authorities said on Friday that Moderna was "already at an advanced stage with its vaccine project," but they did not mention a possible time frame for delivery.
They also said the 4.5 million batches would make it possible to vaccinate 2.25 million people in the country, since double doses are expected to be necessary.
In parallel to this agreement, the Swiss government is continuing talks with other companies in what it calls a "diversified approach" to gaining access to a vaccine.
According to the news source, the federal government has earmarked CHF300 million for the procurement of a vaccine.
To read more NewsPoints articles, click here.